company background image
AADI

Aadi Bioscience NasdaqCM:AADI Stock Report

Last Price

US$13.40

Market Cap

US$326.9m

7D

0.6%

1Y

-30.6%

Updated

04 Dec, 2022

Data

Company Financials +
AADI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

AADI Stock Overview

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes.

Aadi Bioscience, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aadi Bioscience
Historical stock prices
Current Share PriceUS$13.40
52 Week HighUS$26.60
52 Week LowUS$11.00
Beta0
1 Month Change7.11%
3 Month Change-0.45%
1 Year Change-30.64%
3 Year Changen/a
5 Year Changen/a
Change since IPO-48.46%

Recent News & Updates

Aadi Bioscience highlights combination of KRAS inhibitors and nab-sirolimus for tumors

Oct 12

Recent updates

A Look At The Fair Value Of Aadi Bioscience, Inc. (NASDAQ:AADI)

Sep 28
A Look At The Fair Value Of Aadi Bioscience, Inc. (NASDAQ:AADI)

Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?

Jul 06
Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?

What You Need To Know About The Aadi Bioscience, Inc. (NASDAQ:AADI) Analyst Downgrade Today

Nov 27
What You Need To Know About The Aadi Bioscience, Inc. (NASDAQ:AADI) Analyst Downgrade Today

Shareholder Returns

AADIUS BiotechsUS Market
7D0.6%4.2%1.5%
1Y-30.6%-7.4%-14.9%

Return vs Industry: AADI underperformed the US Biotechs industry which returned -7.4% over the past year.

Return vs Market: AADI underperformed the US Market which returned -14.9% over the past year.

Price Volatility

Is AADI's price volatile compared to industry and market?
AADI volatility
AADI Average Weekly Movement5.7%
Biotechs Industry Average Movement11.2%
Market Average Movement7.4%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.3%

Stable Share Price: AADI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: AADI's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200776Neil Desaihttps://aadibio.com

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway.

Aadi Bioscience, Inc. Fundamentals Summary

How do Aadi Bioscience's earnings and revenue compare to its market cap?
AADI fundamental statistics
Market CapUS$326.89m
Earnings (TTM)-US$62.59m
Revenue (TTM)US$10.99m

29.7x

P/S Ratio

-5.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AADI income statement (TTM)
RevenueUS$10.99m
Cost of RevenueUS$31.63m
Gross Profit-US$20.64m
Other ExpensesUS$41.95m
Earnings-US$62.59m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.57
Gross Margin-187.85%
Net Profit Margin-569.57%
Debt/Equity Ratio0%

How did AADI perform over the long term?

See historical performance and comparison